Executive Summary

CONGRESSIONAL FDA OVERSIGHT EXPERIENCE TO DWINDLE IN LIGHT OF STAFF CUTS anticipated in key committees and subcommittees that oversee the agency. The new Republican House leadership said it intends to "review every aspect of the current organizational structure of the House," and may consider trimming the large number of committees and their staffs. The change of control in the House will lead to the dismantling of the large, well- established committee staffs as well as the replacement of the Democratic committee chairs. At Energy & Commerce, Rep. John Dingell's (D-Mich.) aggressive investigative staff will be subject to large cuts.